Startups

Scientist I, Discovery

Basecamp Research · Boston · On-site

← All jobs
About Basecamp Research

The future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how. Backed by True Ventures.

About the role

We are seeking a highly capable and proactive Scientist I to join our Cambridge, MA team. In this role, you will leverage our proprietary biodiversity knowledge to develop transformative solutions in gene editing and cellular engineering. Found on 1752vc Careers, the job board for startup and VC roles.

What they're looking for

  • A PhD in molecular biology, biochemistry, genetics, bioengineering, or a life-sciences related field, or an MSc with equivalent hands-on laboratory experience
  • Experience with gene editing, NGS assay development, protein engineering and cell therapy
  • Experience with high-throughput methods of cloning and producing DNA constructs for cellular screening
  • Experience with mammalian cell culture, transfection, and cell-line generation
  • Knowledge of emerging technologies in gene editing and on/off-target analytics that enable regulatory approval
  • Expertise with DNA/RNA extraction, PCR, ddPCR, NGS library preparation and QC
More about this role

Basecamp Research is building frontier AI for therapeutic design. We believe the future of medicine lies in reprogramming the body to repair itself, and we design the models and the medicines to teach it how.

Our EDEN models are trained on BaseData, the world's largest proprietary genomic dataset, with over 10B genes collected through partnerships in more than 30 countries across all seven continents. This gives our AI models access to genetic diversity that doesn't exist in public databases, and enables EDEN to design cell and gene therapies, enzymes, and peptides directly from information about a disease. Our pipeline of EDEN-designed therapeutics, beginning with in vivo cell therapy, is advancing towards clinical development.

In September 2026 we closed an oversubscribed $140M Series C led by S32, with participation from NVIDIA, Anthropic's Anthology Fund, Catalio, European Tech Collective, Firebrand River Capital, King Philanthropies, NATO Innovation Fund, NVentures (NVIDIA's venture arm), Redalpine, Rockefeller Foundation, Singular, Sovereign AI and True Ventures. We have offices and labs in London and Boston, we partner with biopharma companies and academic institutions...

Read the full posting on Basecamp Research's site ↗

Science

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.